Lilly Wins FDA Approval for New Drug to Slow Alzheimer’s Disease

Clogged Bank Balance Sheets Cause Key Repo Funding Rate to SpikeAsia Port Snarls Spread With Ship Delays Looking to Last Into AugustNew York City’s Fiscal Crisis That Never WasLula Says Central Bank Can’t Be at the Service of MarketsPresident Milei Proves Boon and Curse for Argentine Bank StocksChile Taps Debt Markets With 7-Year Social BondPG&E Cuts Power to 2,000 as Extreme Heat Bakes CaliforniaEther ETF Hopefuls Gear Up for SEC Approval as Soon as Mid-JulyPowell Welcomes Recent Data But...

What you should knowFirst 2024 Canada carbon rebates will be deposited today for some CanadiansThe big benefits of adopting a debt-free lifestylePowell Welcomes Recent Data But Fed Needs More Confidence to CutHomebuilders Cut on ‘Sluggish’ Housing Market, Florida ConcernsAbu Dhabi’s Original Hedge Fund Island Is Running Out of Office SpaceChina New Home Sales Struggle in Face of Lopsided RecoveryShift Occurring in US Housing Market as Mortgage Lock Loosens UpSwedish Housing Prices Rise for...

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s DrugUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s experimental Alzheimer’s disease treatment than the company wants, potentially limiting the market for a would-be blockbuster.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

FDA panel votes unanimously for Eli Lilly's Alzheimer's treatmentAn FDA panel voted unanimously to support Eli Lilly's Alzheimer's drug for use in adults 60-85 years old.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Lilly Alzheimer’s Drug Seen Effective by FDA Advisory PanelEli Lilly & Co.’s treatment for Alzheimer’s disease works in at least some patients, according to a US advisory panel.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

Gene Therapy for Kids’ Deadly Disease Wins Broader FDA ApprovalSarepta Therapeutics Inc.’s gene therapy received expanded US approval to include more children with a deadly muscle disease, expanding the market for a controversial treatment that still hasn’t proved its benefit in clinical trials.
Source: BNNBloomberg - 🏆 83. / 50 Read more »